These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25970253)

  • 21. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
    Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
    AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical differences and viral diversity between newly HIV type 1-diagnosed African and non-African patients in Spain (2005-2007).
    Yebra G; Rivas P; Herrero MD; López M; de Mulder M; Puente S; Ramírez-Olivencia G; Soriano V; Holguín A
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):37-44. PubMed ID: 19182919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
    Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
    N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Settings for identifying recent HIV infections: the Portuguese experience.
    Cortes Martins H; Paixao M
    Euro Surveill; 2008 Sep; 13(36):. PubMed ID: 18775290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+ T cell count, HIV-1 viral loads and demographic variables of newly identified patients with HIV infection in Wuhan, China.
    Liu MQ; Tang L; Kong WH; Zhu ZR; Peng JS; Wang X; Yao ZZ; Schilling R; Zhou W
    J Med Virol; 2013 Oct; 85(10):1687-91. PubMed ID: 23861066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing high-throughput HIV incidence assay with pyrosequencing platform.
    Park SY; Goeken N; Lee HJ; Bolan R; Dubé MP; Lee HY
    J Virol; 2014 Mar; 88(5):2977-90. PubMed ID: 24371062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can we stop CD4+ testing in patients with HIV-1 RNA suppression on antiretroviral treatment?
    Girard PM; Nelson M; Mohammed P; Hill A; van Delft Y; Moecklinghoff C
    AIDS; 2013 Nov; 27(17):2759-63. PubMed ID: 23842127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends on epidemiological, virological, and clinical features among newly diagnosed HIV-1 persons in Northwest Spain over the last 10 years.
    Pernas B; Mena A; Cañizares A; Grandal M; Castro-Iglesias A; Pértega S; Pedreira JD; Poveda E
    J Med Virol; 2015 Aug; 87(8):1319-26. PubMed ID: 25777786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extended antiretroviral treatment interruption in HIV-infected patients with long-term suppression of plasma HIV RNA.
    Achenbach CJ; Till M; Palella FJ; Knoll MD; Terp SM; Kalnins AU; Murphy RL
    HIV Med; 2005 Jan; 6(1):7-12. PubMed ID: 15670246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata.
    Reekie J; Gatell JM; Yust I; Bakowska E; Rakhmanova A; Losso M; Krasnov M; Francioli P; Kowalska JD; Mocroft A;
    AIDS; 2011 Nov; 25(18):2259-68. PubMed ID: 21918422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Detection of the viral load and its use as a virological marker in the follow-up of HIV-1-positive patients].
    Hodara VL; Monticelli A; Benetucci J; Lasala M; Jauregui Rueda H; Libonatti O; García Messina O; Reboredo G; Bogdanowicz E; Bases O; Pampuro S; Salomón H
    Rev Argent Microbiol; 1998; 30(1):1-7. PubMed ID: 9629601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced community viral load does not coincide with a reduction in the rate of new HIV diagnoses and recent infections: data from a region of southern Italy.
    Monno L; Saracino A; Scudeller L; Santoro C; Brindicci G; Punzi G; Lagioia A; Lo Caputo S; Angarano G
    HIV Med; 2017 Nov; 18(10):711-723. PubMed ID: 28444818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated risk for invasive meningococcal disease among persons with HIV.
    Miller L; Arakaki L; Ramautar A; Bodach S; Braunstein SL; Kennedy J; Steiner-Sichel L; Ngai S; Shepard C; Weiss D
    Ann Intern Med; 2014 Jan; 160(1):30-7. PubMed ID: 24166695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2.
    van der Loeff MF; Awasana AA; Sarge-Njie R; van der Sande M; Jaye A; Sabally S; Corrah T; McConkey SJ; Whittle HC
    Int J Epidemiol; 2006 Oct; 35(5):1322-8. PubMed ID: 16543363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.
    Verhofstede C; Fransen K; Van Den Heuvel A; Van Laethem K; Ruelle J; Vancutsem E; Stoffels K; Van den Wijngaert S; Delforge ML; Vaira D; Hebberecht L; Schauvliege M; Mortier V; Dauwe K; Callens S
    BMC Infect Dis; 2017 Nov; 17(1):738. PubMed ID: 29187159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.